Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-4346

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-4346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 (Table 5)

A data table titled 'Effect of Single Daily Doses of Oral Pantoprazole on Intragastric pH' showing median pH values on day 7 at different time intervals (8 a.m. to 8 a.m., 8 a.m. to 10 p.m., and 10 p.m. to 8 a.m.) for placebo and oral pantoprazole doses of 20 mg, 40 mg, and 80 mg. The table includes footnotes indicating statistical significance compared to placebo and the 20 mg dose.*

FDA Label Image

8 (Table 8)

A data table titled 'Table 8: Erosive Esophagitis Healing Rates (Per Protocol)' comparing healing rates at 4 and 8 weeks among groups receiving Pantoprazole at 10 mg and 20 mg daily doses and a placebo group at 40 mg daily. The table includes statistical significance notations for differences between treatment groups.*

FDA Label Image

9 (Table 9)

A table titled 'Erosive Esophagitis Healing Rates (Per Protocol)' comparing healing rates of Pantoprazole 20 mg daily, Nizatidine 40 mg daily, and Nizatidine 150 mg twice daily at weeks 4 and 8. The table includes sample sizes (n) for each group and shows higher healing percentages for Pantoprazole and the 40 mg Nizatidine dose versus the 150 mg twice daily Nizatidine dose.*

FDA Label Image

Bag Label (Image 01)

Pantoprazole Sodium delayed-release tablets, USP 20 mg, in a 10 unit dose tablet package. The label includes storage instructions, dosage form, strength, and warnings about child resistance and institutional use. Manufactured for AvKARE and distributed by Cardinal Health, Dublin, OH. NDC 55154-4346.*

FDA Label Image

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)

Chemical structure of Pantoprazole Sodium, shown as a molecular diagram with labeled atoms and bonds, including sodium ion (Na+), functional groups, and associated water molecules (1.5 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.